
Misook Yu
Supervisory Patent Examiner (ID: 17396, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1641, 1642 |
| Total Applications | 873 |
| Issued Applications | 267 |
| Pending Applications | 202 |
| Abandoned Applications | 406 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 72178
[patent_doc_number] => 07754857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Human p51 genes and gene products thereof'
[patent_app_type] => utility
[patent_app_number] => 12/169213
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26346
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12169213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/169213 | Human p51 genes and gene products thereof | Jul 7, 2008 | Issued |
Array
(
[id] => 6499630
[patent_doc_number] => 20100215615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/452264
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5262
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215615.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452264
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452264 | IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS | Jun 24, 2008 | Abandoned |
Array
(
[id] => 4852498
[patent_doc_number] => 20080318241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Methods and Systems for Detecting Antiangiogenesis'
[patent_app_type] => utility
[patent_app_number] => 12/140778
[patent_app_country] => US
[patent_app_date] => 2008-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8744
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318241.pdf
[firstpage_image] =>[orig_patent_app_number] => 12140778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140778 | Methods and Systems for Detecting Antiangiogenesis | Jun 16, 2008 | Abandoned |
Array
(
[id] => 6070157
[patent_doc_number] => 20110045007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE'
[patent_app_type] => utility
[patent_app_number] => 12/602416
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 48160
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045007.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602416
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602416 | FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE | May 29, 2008 | Abandoned |
Array
(
[id] => 5495810
[patent_doc_number] => 20090263838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Method for determining a lung cancer treatment and method for determining the effectiveness of an agent for treatment of lung cancer'
[patent_app_type] => utility
[patent_app_number] => 12/155148
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6588
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263838.pdf
[firstpage_image] =>[orig_patent_app_number] => 12155148
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/155148 | Method for determining a lung cancer treatment and method for determining the effectiveness of an agent for treatment of lung cancer | May 29, 2008 | Abandoned |
Array
(
[id] => 4697774
[patent_doc_number] => 20080219958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'METHOD FOR INDUCING AN ANTI-TUMOR AND ANTI-CACHEXIA IMMUNE RESPONSE IN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 12/126744
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5853
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219958.pdf
[firstpage_image] =>[orig_patent_app_number] => 12126744
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/126744 | Method for inducing an anti-tumor and anti-cachexia immune response in mammals | May 22, 2008 | Issued |
Array
(
[id] => 5440914
[patent_doc_number] => 20090092553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'MONOCARBOXYLATE TRANSPORTERS EXPRESSED IN CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/122574
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13582
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20090092553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12122574
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/122574 | MONOCARBOXYLATE TRANSPORTERS EXPRESSED IN CANCER CELLS | May 15, 2008 | Abandoned |
Array
(
[id] => 5342822
[patent_doc_number] => 20090181472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'LABELED MOLECULE FOR PROGNOSING TUMOR GRADE OF HEAD NECK CANCER AND METHOD FOR THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/117001
[patent_app_country] => US
[patent_app_date] => 2008-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1164
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12117001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/117001 | LABELED MOLECULE FOR PROGNOSING TUMOR GRADE OF HEAD NECK CANCER AND METHOD FOR THE SAME | May 7, 2008 | Abandoned |
Array
(
[id] => 4960045
[patent_doc_number] => 20080274470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/114584
[patent_app_country] => US
[patent_app_date] => 2008-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3897
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12114584
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/114584 | NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER | May 1, 2008 | Abandoned |
Array
(
[id] => 5289925
[patent_doc_number] => 20090022655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Nanotubes for Cancer Therapy and Diagnostics'
[patent_app_type] => utility
[patent_app_number] => 12/112986
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10810
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022655.pdf
[firstpage_image] =>[orig_patent_app_number] => 12112986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/112986 | Nanotubes for cancer therapy and diagnostics | Apr 29, 2008 | Issued |
Array
(
[id] => 4739476
[patent_doc_number] => 20080233129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Ligand that has binding specificity for IL-4 and/or lL-13'
[patent_app_type] => utility
[patent_app_number] => 12/150487
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 50160
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233129.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150487
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150487 | Ligand that has binding specificity for IL-4 and/or lL-13 | Apr 28, 2008 | Abandoned |
Array
(
[id] => 4739477
[patent_doc_number] => 20080233130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Ligand that has binding specificity for IL-4 and/or IL-13'
[patent_app_type] => utility
[patent_app_number] => 12/150567
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 50095
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150567
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150567 | Ligand that has binding specificity for IL-4 and/or IL-13 | Apr 28, 2008 | Abandoned |
Array
(
[id] => 5322874
[patent_doc_number] => 20090060864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies'
[patent_app_type] => utility
[patent_app_number] => 12/148629
[patent_app_country] => US
[patent_app_date] => 2008-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13764
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060864.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148629 | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies | Apr 20, 2008 | Issued |
Array
(
[id] => 5458226
[patent_doc_number] => 20090258378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'STRESS-INDUCED PHOSPHOPROTEIN 1 AS A BIOMARKER FOR THE DETECTION OF HUMAN OVARIAN CANCERS AND ENDOMETRIOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/102807
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8355
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258378.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102807 | Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis | Apr 13, 2008 | Issued |
Array
(
[id] => 177700
[patent_doc_number] => 07655408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'PCA3 messenger RNA species in benign and malignant prostate tissues'
[patent_app_type] => utility
[patent_app_number] => 12/098577
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13313
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655408.pdf
[firstpage_image] =>[orig_patent_app_number] => 12098577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/098577 | PCA3 messenger RNA species in benign and malignant prostate tissues | Apr 6, 2008 | Issued |
Array
(
[id] => 4683161
[patent_doc_number] => 20080249387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Enhanced monitor compliance'
[patent_app_type] => utility
[patent_app_number] => 12/080318
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4097
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080318 | Enhanced monitor compliance | Apr 1, 2008 | Abandoned |
Array
(
[id] => 4561088
[patent_doc_number] => 07846447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction'
[patent_app_type] => utility
[patent_app_number] => 12/077508
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7461
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077508 | Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction | Mar 18, 2008 | Issued |
Array
(
[id] => 4727235
[patent_doc_number] => 20080206777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/072651
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11130
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206777.pdf
[firstpage_image] =>[orig_patent_app_number] => 12072651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/072651 | Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors | Feb 26, 2008 | Abandoned |
Array
(
[id] => 4718542
[patent_doc_number] => 20080241064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN'
[patent_app_type] => utility
[patent_app_number] => 12/036875
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26583
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241064.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036875 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN | Feb 24, 2008 | Abandoned |
Array
(
[id] => 4676152
[patent_doc_number] => 20080213782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'SOCS-1 Gene Methylation in Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/036182
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29224
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213782.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036182 | SOCS-1 gene methylation in cancer | Feb 21, 2008 | Issued |